Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
Researchers have developed a new gene therapy approach for children with severe combined immunodeficiency.
The accelerated approval pathway may offer a faster route to approval for new treatments in significant, unmet medical needs.
A common mutation makes mouse tumors more vulnerable to certain cancer drugs.
The animals have 100 times as many cells as humans but rarely get cancer. New gene studies may help explain why.
We need to make certain we assure patient safety and adequately characterize the potential risks and benefits of these products.
New immunotherapy approach could make engineering immune cells faster and cheaper.
This emerging area of treatment could hold incredible promise –– but critics are wary of its approach.
For example: Hep C cures have meant fewer people to treat and fewer transmissions to potential patients.
Finding could facilitate more effective therapies for dangerous subset of meningiomas
Fred Hutch experts lend their predictions for the coming year’s advances
The FoundationOne CDx can look for mutations in hundreds of cancer genes at once, which can help find more efficient treatments.
New CRISPR-based genetic diagnostic tool that may make it faster and easier to diagnose acute and chronic diseases.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.